Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
NewCo’s pipeline includes five investigational medicines
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Subscribe To Our Newsletter & Stay Updated
